CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Mar. 31, 2016	Mar. 31, 2015	Mar. 31, 2014
Cash Flows From Operating Activities:
Net earnings	$ 44,747	$ 45,840	$ 35,273
Adjustments to reconcile net earnings to net cash (used in) provided by operating activities:
Depreciation and amortization	15,980	15,575	14,755
Reserve for credit losses, inventory obsolescence and sales returns	(216)	125	853
Share-based compensation expense	5,711	4,585	3,968
Excess tax benefit from share-based compensation	(728)	(564)	(1,762)
Deferred taxes	3,515	(1,863)	(3,536)
Payments from lessees directly to lenders-operating leases	(4,646)	(7,685)	(7,539)
Gain on disposal of property, equipment and operating lease equipment	(3,104)	(3,112)	(2,473)
Gain on sale of financing receivables	(7,103)	(5,884)	(5,843)
Excess increase in cash value of life insurance	0	0	(103)
Gain on settlement	0	(1,434)	0
Other	185	(127)	109
Changes in:
Accounts receivable - trade	(8,564)	1,372	(36,751)
Accounts receivable - other	(2,498)	(2,407)	(2,621)
Inventories	(13,405)	3,161	(7,724)
Financing receivables - net	(9,310)	(19,560)	(30,792)
Deferred costs, other intangible assets and other assets	11,189	(10,060)	(1,179)
Accounts payable-trade	(738)	(16,810)	33,090
Salaries and commissions payable, deferred revenue and other	(17,633)	12,695	4,052
Net cash provided by (used in) operating activities	13,382	13,847	(8,223)
Cash Flows From Investing Activities:
Maturities of short-term investments	0	0	982
Maturities of supplemental benefit plan investments	0	2,544	0
Proceeds from sale of property, equipment and operating lease equipment	6,931	8,562	4,138
Purchases of property, equipment and operating lease equipment	(14,468)	(11,773)	(9,952)
Purchases of assets to be leased or financed	(11,403)	(143)	(5,445)
Issuance of financing receivables	(137,008)	(128,125)	(104,298)
Repayments of financing receivables	58,067	60,619	42,514
Proceeds from sale of financing receivables	64,351	45,828	46,249
Premiums paid on life insurance	0	(47)	(140)
Cash used in acquisitions, net of cash acquired	(16,649)	(8,057)	(2,845)
Net cash used in investing activities	(50,179)	(30,592)	(28,797)
Cash Flows From Financing Activities:
Borrowings of non-recourse and recourse notes payable	44,807	52,237	51,547
Repayments of non-recourse and recourse notes payable	(257)	(1,688)	(2,252)
Repurchase of common stock	(11,339)	(37,685)	(13,188)
Dividends paid	(80)	(90)	(108)
Proceeds from issuance of capital stock through option exercise	0	0	560
Payments of contingent consideration	(1,158)	0	(1,027)
Excess tax benefit from share based compensation	728	564	1,762
Net borrowings (repayments) on floor plan facility	22,475	(518)	27,165
Net cash provided by financing activities	55,176	12,820	64,459
Effect of exchange rate changes on cash	212	(79)	20
Net Increase (Decrease) in Cash and Cash Equivalents	18,591	(4,004)	27,459
Cash and Cash Equivalents, Beginning of Period	76,175	80,179	52,720
Cash and Cash Equivalents, End of Period	94,766	76,175	80,179
Supplemental Disclosures of Cash Flow Information:
Cash paid for interest	84	239	105
Cash paid for income taxes	29,789	35,436	25,517
Schedule of Non-Cash Investing and Financing Activities:
Proceeds from sales of operating lease equipment included in accounts receivable	7,650	443	861
Purchase of property, equipment, and operating leases included in accounts payable	(10,562)	(432)	(123)
Purchase of assets to be leased or financed included in accounts payable	(9,827)	(20,022)	(1,140)
Issuance of financing receivables	(101,718)	(73,881)	(98,616)
Repayment of financing receivables	16,873	0	0
Proceeds from sale of financing receivables	98,753	73,881	98,616
Borrowing of recourse and nonrecourse notes payable	42,840	0	0
Repayments of non-recourse and recourse notes payable	(29,059)	(34,584)	(22,146)
Vesting of share-based compensation	7,799	6,474	7,838
Contingent consideration	$ 0	$ (1,980)	$ 0